RNDr. Narcisa Tribulová, DrSc.
International
Finished
- Investigation of the mechanims involved in antiarrhythmic effects of melatoninProgram: Bilateral - otherDuration: 1. 5. 2014 – 31. 12. 2020
- Multidisciplinary analysis of the combined effects of thyroid hormones and n-3 polyunsaturated fatty acids in ratsProgram: Inter-academic agreementDuration: 1. 1. 2015 – 31. 12. 2017
- Study of cellular and molecular mechamisms involved in cardioprotective effects of red palm oil.Program: Bilateral - otherDuration: 1. 1. 2010 – 31. 12. 2015
- Investigation of the cardioprotection against injury and malignant arrhythmias induced by altered thyroid status.Program: Inter-governmental agreementDuration: 1. 1. 2014 – 31. 12. 2015
- Investigation of the effects of omega-3 fatty acids and red palm oil in rats with altered thyroid statusProgram: Inter-academic agreementDuration: 1. 1. 2012 – 31. 12. 2014
- Investigation of the cardioprotection from injury and malignant arrhythmias induced by altered thyroid statuses.Program: Inter-governmental agreementDuration: 1. 1. 2012 – 31. 12. 2013
- Role of membranes mechanisms (omega-3 unsaturated fatty acids and connexin-43) in pathology of cardiovascular diseasesProgram: Inter-academic agreementDuration: 1. 1. 2008 – 31. 12. 2013
- Chronic ischemic injury of the heart: Influence of ionizing radiation on cardiovascular system and possibilities to minimize its adverse effectProgram: Bilateral - otherDuration: 1. 1. 2007 – 31. 12. 2012
- Omega-3 index and disclosure the novel mechanisms of omega-3 fatty acids actions involved in cardiac disease and arrhythmia protection.Program: Inter-governmental agreementDuration: 1. 1. 2010 – 31. 12. 2011
- Investigation of factors determining malignant arrhythmias and their prevention by omega-3 fatty acids in cardiomyopathic rats.Program: Inter-academic agreementDuration: 1. 1. 2009 – 31. 12. 2011
- Physiological, pharmacological, morphological and molecular studies on the role of myocardial gap junctions in initiation and termination of cardiac arrhythmiasProgram: Bilateral - otherDuration: 1. 1. 2000 – 31. 12. 2010
- Study of arrhythmogenic and antiarrhythmic mechanisms in the myocardiumProgram: Bilateral - otherDuration: 1. 1. 1993 – 31. 12. 2010
- Role of membrane mechanisms (omega-3 fatty acids and connexin-43) in pathology of cardiovascular diseaseProgram: Inter-academic agreementDuration: 1. 1. 2008 – 31. 12. 2010
National
Current
- Targeted suppression of pro-inflammatory and pro-fibrotic signaling pathways to prevent heart failure and occurrence of malignant arrhythmiasProgram: SRDADuration: 1. 7. 2022 – 30. 6. 2026
Finished
- The role of miRNAs in the onset and progression of cardiovascular diseases - new approach to the protection of the heart in situations of increased production of reactive oxygen speciesProgram: SRDADuration: 1. 7. 2020 – 30. 6. 2024
- Are connexin channels involved in extracellular matrix remodeling of overloaded heart?Program: VEGADuration: 1. 1. 2020 – 31. 12. 2023
- The role of matrix metalloproteinases in pathophysiology of cardiovascular system diseases and their relation to cellular redox signaling.Program: SRDADuration: 1. 7. 2019 – 30. 6. 2023
- Modulation of dysregulation of extracellular matrix and intercellular communication as a heart protection from its functional failureProgram: VEGADuration: 1. 1. 2019 – 31. 12. 2022
- Heart protection in situations of excessive formation of oxygen and nitrosyl radicals: Molecular hydrogen as a new potential therapeutic tool?Program: VEGADuration: 1. 1. 2018 – 31. 12. 2021
- New methods to improve diagnostics, prevention, and treatment of cardiovascular diseases with focus on oxidative stress. Protection from radiation-induced heart damage. Reperfusion injury - heart transplantationProgram: Other projectsDuration: 1. 12. 2018 – 31. 12. 2019
- Investigation of regulatory mechanisms of cardiac cell-cell communication for targeted protection from heart failure.Program: VEGADuration: 1. 1. 2016 – 31. 12. 2019
- Study of regulation of radical and cellular signaling during hypertension and influence of novel therapies on this signaling.Program: SRDADuration: 1. 10. 2013 – 30. 9. 2017
- -Program: VEGADuration: 1. 1. 2012 – 31. 12. 2015
- Investigation of the cardioprotection using n-3 PUFA against injury and malignant arrhythmias induced by altered thyroid status.Program: SRDADuration: 1. 1. 2014 – 31. 12. 2015
- Effects of melatonin, omega-3 fatty acids and aliskiren on myocardial connexin-43 and heart function in rats with CVD.Program: Other projectsDuration: 12. 10. 2012 – 31. 12. 2014
- Influence of ionizing radiation on cardiovascular system and possibilities to minimize its adverse effectProgram: VEGADuration: 1. 1. 2011 – 31. 12. 2013
- Antiinflammatory protection of intercellular communication of cardiovascular system.Program: VEGADuration: 1. 1. 2010 – 31. 12. 2012
- The role of connexins in protection of the heart against letal arrhythmias and failureProgram: VEGADuration: 1. 1. 2009 – 31. 12. 2011
- Molecular mechanisms of new drugs influencing oxidative stress - important ethiopathogenetic factor of numerous diseasesProgram: SRDADuration: 1. 9. 2006 – 31. 10. 2009
- Protection of the heart against malignant arrhythmias and heart failure.Program: SRDADuration: 2. 5. 2006 – 30. 4. 2009
- Molecular mechanisms of action of new drugs interfering with oxidative stress – the important factor in etiopathogenesis of numerous diseases.Program: SRDADuration: 1. 3. 2006 – 1. 2. 2009
- Cardiac gap junctions a potential therapeutic targetProgram: VEGADuration: 1. 1. 2006 – 1. 12. 2008
- Endothelial integrity in the injured myocardiumProgram: VEGADuration: 1. 1. 2005 – 1. 12. 2007